BIOBASE introduces Genome Trax Next Generation Sequencing solution

NewsGuard 100/100 Score

BIOBASE announced today that it is entering the Next Generation Sequencing (NGS) market with the launch of a new solution. Genome Trax™ enables researchers to identify genome variations of functional significance by mapping them to known elements such as gene regulatory sites and disease-linked mutations. Researchers interpreting large numbers of sequence variants can now easily distinguish those variants that have biological importance. Genome Trax contains unique, manually-curated data from peer-reviewed literature, and is designed for seamless integration into existing NGS analysis workflows.

Dr. Frank Schacherer of BIOBASE GmbH said, "We have a powerful dataset that has been used for many high-profile human genome projects, such as the Craig Venter and the 1000 Genomes project. With Genome Trax, we are making this data available in a form that is easy to use, and are confident it will greatly facilitate discovery in this important field of research."


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Breakthrough in CRISPR delivery promises safer gene editing